More than 20 years have passed since the first description of endoscopic placement of a
prosthesis for the palliation of rectal cancer by Dohmoto et al, 1 although it still remains a …

Background Colonic stenting has emerged as preferred palliative treatment for left sided
malignant obstructions. It shortens hospital stays, decreases healthcare cost, reduces …

Colorectal cancer (CRC) is the 3 rd most common cancer in the United States with more
than 10000 new cases diagnosed annually. Approximately 20% of patients with CRC will …

Colonic strictures, both benign and malignant, are commonly encountered in clinical
practice by both gastroenterologists and surgeons. Benign strictures are most commonly …

Background and aims Self-expandable metallic stents (SEMS) can be used to treat
malignant colorectal obstruction (MCO). Guidewire insertion to the proximal site of MCO is …

Colonic stents have been used for more than 20 years for preoperative and palliative relief
of malignant colonic obstruction. Self-expandable metal stent (SEMS) placement is more …

Aims. Endoscopic self‐expandable metallic stent (SEMS) insertion for acute colonic
obstruction caused by colorectal cancer (CRC) is always performed under fluoroscopic …

Aims: This study aimed to identify risk factors related to guidewire insertion (GWI) failure and
construct a novel predictive nomogram. In addition, sphincterotome-assisted guidewire …

The self-expandable metal stent (SEMS) was placed endoscopically for the first time in 1992
for palliation of obstruction from rectal cancer. 1 Since that time, the use of expandable …

Colorectal cancer can start as an intestinal obstruction in 8%–13% of cases and is more
frequent when the neoplasm is in the splenic flexure or left colon. In this context, since 1991 …